Clinical Trials on Unresectable Hepatocellular Carcinoma in France

Total 2828 results

Commissariat A L'energie Atomique
Assistance Publique - Hôpitaux de Paris

Unknown

Evaluation of 11 C-Choline PET-CT for Detection of Hepatocellular Carcinoma (CHOLPET)

Hepatocellular Carcinoma

France
Hospices Civils de Lyon

Unknown

Netrin-1 & Hepatocellular Carcinoma HCC (HCC-Net)

HCC

France
Assistance Publique - Hôpitaux de Paris

Completed

Perception of the Doctor/Patient Relationship, Disease and Treatment Among Physicians and Their Patients Treated With Systemic Therapy for Hepatocellular Carcinoma "PERCEPTION1" (PERCEPTION1)

Hepatocellular Carcinoma

France
University Hospital, Grenoble
NETRIS Pharma

Recruiting

Study Investigating the Association of NP137 With Atezolizumab-Bevacizumab Combination in First Line in Unresectable HCC (Liver-NET1)

Hepatocellular Carcinoma

France
University Hospital, Montpellier

Unknown

Discrepancies in Management of Hepatocellualr Carcinoma Between Practice and Recommendations

Hepatocellular Carcinoma

France
University Hospital, Montpellier

Unknown

Changing Trends in HCC Procedures

Hepatocellular Carcinoma

France
University Hospital, Lille

Recruiting

PET TDM FDG-Choline as a Decision-making Tool for Routine Care on the Liver Transplant List for HCC (TEP CARE)

Hepatocellular Carcinoma | Liver Transplant

France
Centre Hospitalier Universitaire Dijon

Completed

Environmental, Metabolic and Nutritional Factors of Hepatocellular Carcinoma in Cirrhotic Patients (CIRCE)

Cirrhosis With Hepatocellular Carcinoma | Cirrhosis Without Hepatocellular Carcinoma

France
Assistance Publique - Hôpitaux de Paris
General Electric

Completed

Study of Automatic Image Fusion of a CT Volume With Ultrasound During Percutaneous Ablation Treatment of Hepatic Tumors (IAT)

Hepatocellular Carcinoma

France
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Multi-modal Characterisation of Hepatocellular Carcinoma (HCC) Treated With Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National Cohort (OPERANDI-HCC)

Hepatocellular Carcinoma | Radioembolization

France
Centre Hospitalier Universitaire, Amiens
Federation Francophone de Cancerologie Digestive; UNICANCER; Société Nationale... and other collaborators

Recruiting

Prospective Cohort of Patients With Hepatocellular Carcinoma in France (CHIEF)

Hepatocellular Carcinoma | Cancer of Liver

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Cohort of Patients With Hepatocellular Carcinoma or Cholangiocarcinoma (CHC/CC)

Hepatocellular Carcinoma | Cholangiocarcinoma

France
Assistance Publique - Hôpitaux de Paris

Unknown

Interest of the Intervention of a Nurse Coordinator in Complex Care Pathway (INFIC)

Hepatocellular Carcinoma

France
Centre Hospitalier Universitaire, Amiens

Completed

Contribution of the Perfusion Scanner in the Prediction of the Tumor Control of Patients With Hepatocellular Carcinoma Treated With Sorafenib. (HCC-CTPerf)

Hepatocellular Carcinoma | Perfusion Scanner

France
Centre Hospitalier Universitaire, Amiens

Withdrawn

Analysis of the Role of Hepatocyte SLAMF3 Receptor and Drug Resistance Proteins (MDR) in Resistance to Treatment With Sorafenib in CHC Patients (SLAMF3)

Hepatocellular Carcinoma | Hepatocyte Receptor

France
University Hospital, Montpellier

Completed

Pathological Results of Aggressive Hepatocellular Carcinomas Treated Using SIRT (PAHCHS)

Hepatocellular Carcinoma

France
Gustave Roussy, Cancer Campus, Grand Paris
Hoffmann-La Roche

Unknown

Bevacizumab in Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma

France
Replimune Inc.
Roche Pharma AG

Not yet recruiting

RP3 in Combination With 1L or 2L Therapy in Patients With Locally Advanced Unresectable or Metastatic HCC

Recurrent Hepatocellular Carcinoma | Metastatic Hepatocellular Carcinoma | Locally Advanced Hepatocellular Carcinoma

United States, United Kingdom, France, Germany, Greece
Assistance Publique - Hôpitaux de Paris

Completed

Interest of elastoFRM With Force Measure by MRI on Patients With Hepatocellular Cancer (FORCE)

Hepatocellular Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Clinical Investigation Evaluating Safety and Efficacy of Selective Intra-arterial 166Holmium Radiation Therapy in Combination With Atezolizumab and Bevacizumab for Non Resectable Hepatocellular Carcinoma (HOLMBRAVE)

Hepatocellular Carcinoma

France
University Hospital, Montpellier

Completed

Small and Steatotic Hepatocellular Carcinoma

HCC

France
AbbVie

Recruiting

A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC) (LIVIGNO-2)

Hepatocellular Carcinoma

United States, Taiwan, Spain, France
Centre Oscar Lambret
National Cancer Institute, France

Completed

Stereotaxic Irradiation of Hepatocellular Carcinoma (CKNO-HEP)

Hepatocellular Carcinoma

France
University Hospital, Montpellier

Unknown

Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment

Hepatocellular Carcinoma | Cirrhosis

France
University Hospital, Grenoble
University Hospital, Caen; National Cancer Institute, France; Amiens University... and other collaborators

Recruiting

Influence of Social Determinants of Health on the Management of HCC in the French National Cohort Study CHIEF (SOCIAL-CHIEF)

Hepatocellular Carcinoma

France
Centre Hospitalier Universitaire de Besancon
GERCOR - Multidisciplinary Oncology Cooperative Group; PRODIGE

Recruiting

Evaluation of the Interest to Combine a CD4 Th1-inducer Cancer Vaccine Derived From Telomerase and Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma (TERTIO)

Hepatocellular Carcinoma

France
Federation Francophone de Cancerologie Digestive

Not yet recruiting

Study Evaluating the Benefit of Adding Ipilimumab to the Combination of Atezolizumab and Bevacizumab in Patients With Hepatocellular Carcinoma Receiving First-line Systemic Therapy (TRIPLET)

Metastatic Cancer | Metastatic Tumor | HCC - Hepatocellular Carcinoma

France
University Hospital, Montpellier

Withdrawn

The Impact on Hepatic Recurrence After Adjuvant Chemotherapy With Intraarterial Infusion of Idarubicin-Lipiodol (LIDA-ADJ)

Hepatocellular Carcinoma

France
Rennes University Hospital

Terminated

Transarterial Chemoembolization Prior to Transplantation for Hepatocellular Carcinoma (CATCH)

Hepatocellular Carcinoma

France
Center Eugene Marquis

Completed

Internal Radiation Therapy for Hepatocellular Carcinomas With Therasphere: Optimized Dosimetry Versus Standard Dosimetry

Adenoma, Liver Cell

France
Federation Francophone de Cancerologie Digestive

Completed

Chemoembolisation of Hepatocellular Carcinomas Not Subject to Interventive Care by Idarubicin-loaded Beads - IDASPHERE II (IDASPHERE II)

Liver Cancer

France
Nantes University Hospital

Terminated

Immunotherapy of Hepatocellular Carcinoma by Induction of Anti-alpha Fetoprotein Response

Hepatocellular Carcinoma

France
University Hospital, Grenoble

Completed

Microbiota Study in Liver Transplanted Patients (BIM-LT)

Hepatocellular Carcinoma | Cirrhosis | Microbiota | Liver Transplant

France
Assistance Publique - Hôpitaux de Paris

Terminated

Major RF Ablations of Hepatomas Under MR Thermometry Monitoring (ARMTICH)

Hepatocellular Cancer

France
Merrimack Pharmaceuticals

Completed

A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors

Hepatocellular Carcinoma

United States, France
LEO Pharma

Terminated

Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma

Liver Neoplasms

Spain, Canada, France, Italy, United Kingdom
Novartis Pharmaceuticals

Completed

Phase Ib/II Study of INC280 + PDR001 or PDR001 Single Agent in Advanced HCC

Advanced Hepatocellular Carcinoma

Taiwan, Canada, Italy, Korea, Republic of, Hong Kong, Germany, China, France
LEO Pharma

Terminated

Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma

Liver Neoplasms

Canada, France, Italy, Spain, United Kingdom
Hospices Civils de Lyon

Completed

Combined Fluorocholine Positron Emission Tomography and Magnetic Resonance Imaging (FCH-PET/MRI) in Curative Treatment of a Hepatocellular Carcinoma (TOMIC)

Patients Eligible to a Curative Treatment for Primary HCC

France
University Hospital, Bordeaux
National Cancer Institute, France

Completed

Risk Factors of Hepatocellular Carcinomas Developed on Non-fibrotic Liver: Case-control Study (NoFlic Study) (NoFlic)

Hepatocellular Carcinoma

France
Erasmus Medical Center
Radboud University Medical Center; Universitaire Ziekenhuizen KU Leuven; Maastricht... and other collaborators

Terminated

Transarterial Chemoembolization Versus Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma (TRENDY)

Liver Neoplasms

Netherlands, Belgium, France
Centre Hospitalier Universitaire de Nice

Unknown

Hepatocellular Carcinoma in Patients With a Cirrhosis Due to an Alcoholic or a Non Alcoholic Fatty Liver Disease (CHALNA)

Hepatocellular Carcinoma

France
Transgene

Completed

Trial of TG4023 Combined With Flucytosine in Liver Tumors

Hepatocellular Carcinoma

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Value of the Laparoscopic Approach in the Surgical Management of Resectable Hepatocellular Carcinoma (LapCHC)

Hepatocellular Carcinoma

France
Central Hospital, Nancy, France
Institut National de la Santé Et de la Recherche Médicale, France; Groupement... and other collaborators

Recruiting

Circulating Cell-free DNA-based Epigenetic Biomarker mSEPT9 for Hepatocellular Carcinoma Detection in Cirrhosis (SEPT9-CROSS)

Hepatocellular Carcinoma | Cirrhosis

France
Centre Hospitalier Universitaire Dijon

Completed

Comparison of Response and Recurrence Rates Following Percutaneous Microwave Coagulation Therapy Versus Percutaneous Radiofrequency Ablation (Thermoablation)

Hepatocellular Carcinoma | Chronic Liver Disease | Thermoablation

France
Assistance Publique - Hôpitaux de Paris

Completed

Study of Factors Predicting Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma (HCC) (EFAPRE)

Liver Cirrhosis | Hepatocellular Carcinoma | Evidence of Liver Transplantation

France
NovoCure GmbH

Unknown

Effect of Tumor Treating Fields (TTFields, 150kHz) Concomitant With Sorafenib For Advanced Hepatocellular Carcinoma (HCC) (HEPANOVA)

Hepatocellular Carcinoma

Italy, Czechia, France, Germany, Poland, Spain
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

FAST-IRM for HCC suRveillance in pAtients With High risK of Liver Cancer. (FASTRAK)

Hepatocellular Carcinoma | Cirrhosis | Liver Cancer | Chronic Liver Disease

France
Hospices Civils de Lyon

Completed

Evaluation of Postoperative Ascites After Somatostatin Infusion Following Hepatectomy for Hepatocellular Carcinoma (SOMAPROTECT01)

Hepatocellular Carcinoma

France

3

Subscribe